0001209191-23-053186.txt : 20231019
0001209191-23-053186.hdr.sgml : 20231019
20231019170113
ACCESSION NUMBER: 0001209191-23-053186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231017
FILED AS OF DATE: 20231019
DATE AS OF CHANGE: 20231019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krasner Alan Seth
CENTRAL INDEX KEY: 0001435775
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 231335357
MAIL ADDRESS:
STREET 1: C/O CRINETICS PHARMACEUTICALS, INC.
STREET 2: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-17
0
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001435775
Krasner Alan Seth
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON ROAD, BLDG 2
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
1
Common Stock
2023-10-17
4
M
0
7000
12.01
A
50210
D
Common Stock
2023-10-17
4
S
0
7000
30.00
D
43210
D
Non-qualified stock option (Right to Buy)
12.01
2023-10-17
4
M
0
7000
0.00
D
2028-06-15
Common Stock
7000
153473
D
Includes 909 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person.
25% of the shares subject to the option vest on June 16, 2019, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. The stock options are also subject to accelerated vesting as set forth in the employment agreement between the Issuer and the Reporting Person.
/s/ Marc Wilson, as attorney-in-fact
2023-10-19